Skip to main navigation Skip to search Skip to main content

DORA Trial: Phase III Trial of Docetaxel vs. Docetaxel and Radium-223 for Metastatic Castration-Resistant Prostate Cancer (mCRPC)

Project: Research

Project Details

StatusActive
Effective start/end date05/19/21 → 10/1/27

Funding

  • Prostate Cancer Clinical Trials Consortium: $78,640.30